682 related articles for article (PubMed ID: 2689812)
1. Delivery of anticancer drugs.
Zee-Cheng RK; Cheng CC
Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for delivery of chemotherapeutic agents to tumors.
Vijayaraghavalu S; Raghavan D; Labhasetwar V
Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
[TBL] [Abstract][Full Text] [Related]
5. [Intra-arterial infusion chemotherapy: clinical applications and current status of therapeutic effects on various malignant tumors].
Itsubo M; Kameda H
Gan To Kagaku Ryoho; 1989 Feb; 16(2):199-206. PubMed ID: 2645833
[TBL] [Abstract][Full Text] [Related]
6. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
Maeda H; Bharate GY; Daruwalla J
Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
Poste G
Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
[TBL] [Abstract][Full Text] [Related]
8. Role of polyanhydrides as localized drug carriers.
Jain JP; Modi S; Domb AJ; Kumar N
J Control Release; 2005 Apr; 103(3):541-63. PubMed ID: 15820403
[TBL] [Abstract][Full Text] [Related]
9. Concept and clinical evaluation of carrier-mediated anticancer agents.
Zamboni WC
Oncologist; 2008 Mar; 13(3):248-60. PubMed ID: 18378535
[TBL] [Abstract][Full Text] [Related]
10. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
11. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for drug delivery in cancer treatment.
Haley B; Frenkel E
Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
[TBL] [Abstract][Full Text] [Related]
14. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
Krishna R; Mayer LD
Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
[TBL] [Abstract][Full Text] [Related]
15. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
Shirasaka T; Taguchi T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of anticancer agents in relation to formulations and administration routes.
Terwogt JM; Schellens JH; Huinink WW; Beijnen JH
Cancer Treat Rev; 1999 Apr; 25(2):83-101. PubMed ID: 10395834
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery to the brain using polymers.
Domb A; Maniar M; Bogdansky S; Chasin M
Crit Rev Ther Drug Carrier Syst; 1991; 8(1):1-17. PubMed ID: 1868550
[TBL] [Abstract][Full Text] [Related]
18. Polymeric drug delivery systems for localized cancer chemotherapy.
De Souza R; Zahedi P; Allen CJ; Piquette-Miller M
Drug Deliv; 2010 Aug; 17(6):365-75. PubMed ID: 20429844
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles in drug delivery.
Douglas SJ; Davis SS; Illum L
Crit Rev Ther Drug Carrier Syst; 1987; 3(3):233-61. PubMed ID: 3549008
[TBL] [Abstract][Full Text] [Related]
20. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
